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Vaccine efficacy depends on strong long-term development of immune memory and the formation of memory CD8
1 T cells is critical for recall responses to infection. Upon antigen recognition by naïve T cells, the strength of the TcR signal influences the subsequent effector and memory cells differentiation. Here, we have examined the role of Itk, a tyrosine kinase critical for TcR signaling, in CD8
1 effector and memory T cell differentiation during Listeria monocytogenes infection. We found that the reduced TcR signal strength in Itk deficient naïve CD8
1 T cells enhances the generation of memory T cells during infection. This is accompanied by increased early Eomesodermin, IL-7Ra expression and memory precursor effector cells. Furthermore, Itk is required for optimal cytokine production in responding primary effector cells, but not secondary memory responses. Our data suggests that Itk-mediated signals control the expression of Eomesodermin and IL-7Ra, thus regulating the development of memory CD8
1 T cells, but not subsequent response of memory cells.
C

D8
1 T cells play critical roles in the immune response to pathogens and vaccine efficacy depends on strong long-term development of immune memory in both the B cell and T cell compartment. Memory CD8 1 T cells develop following antigenic stimulation over several identifiable phases. Initial antigen recognition initiates clonal expansion of naïve T cells, which develop into effector T cells. Upon antigen clearance, these effector T cells undergo a contraction phase, and the development of memory precursor effector cells leading to memory T cells. Using mouse models and model pathogens such as Lymphocytic Choriomeningitis Virus (LCMV) and Listeria monocytogenes (L. monocytogenes), these phases have been identified based on expression of surface markers and transcription factors (for review see ref. 1) . The development of memory T cells requires signals from the cytokines IL-15 and IL-7 and expression of the common receptor chain for both cytokines IL-7Ra (CD127) 1 , and responding naïve CD8
1 T cells develop into Short-Lived Effector Cells (SLECs) carrying the phenotype CD127 lo /KLRG1 hi . Once the pathogen is cleared, some effector cells become Memory Precursor Effector Cells (MPECs) and take on the phenotype CD127 hi /KLRG1 lo . SLECs express higher levels of transcription factor T-bet and lower levels of Eomesodermin (Eomes) (higher T-bet5Eomes ratio), while MPECs exhibit the reverse behavior, expressing higher levels of Eomes and lower levels of T-bet. Thus KLRG1 hi /T-bet hi cells are generally SLECs while KLRG1 lo /Eomes hi are generally destined to become long-term memory cells 1 . The parameters for optimal development of the CD8 1 T cell immune response have been of keen interest. The strength of the signal that T cells receive via the TcR is one important factor in generation of effector and memory cells. Antigen dose has been used as a proxy for TcR signal strength, and has been shown to be inversely correlated with CD127 expression 2 . It has also been suggested that short or weak TcR stimuli results in unfit cells that do not survive in vivo 3 . Bevan and colleagues have also reported that CD8 1 T cells that receive short and weak stimuli generate fewer memory T cells, although the resultant populations have the same functional capacity as T cells that received strong signals 4, 5 . These data suggest a direct correlation between TcR signal strength and T cell response for generation of memory. The tyrosine kinase Itk acts downstream of the TcR to regulate TcR signal strength 6 . As a result, Itk deficiency in mice and humans affects the development and function of CD4 1 , CD8 1 T cells, iNKT cells and cd T cells [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . In addition, Itk 2/2 CD4 1 T cells exhibit reduced Th2 responses, and reduced IL-17A production in Th17 cells [17] [18] [19] Itk regulates the quality of the antigen-specific CD8 1 T cell cytokine response in vitro in a digital-like manner. Isolated naïve WT and Itk 2/2 T cells were co-cultured in vitro with SIINFEKL peptide-pulsed dendritic cells (DCs) at varying concentrations. After 5 days, the cells were restimulated using the same initial concentration of peptide and then analyzed for expression of cytokines and transcription factors as a measure of their response. Given the role of Itk in regulating TcR signals, we were surprised to find that Itk 2/2 T cells proliferated similarly to, or better than WT T cells as measured by cell numbers and expression of proliferative marker Ki67 (Fig. 1A) . However, a higher frequency of WT T cells produced IFN-c and TNFa, as well as amount of cytokine/cell as measured by the MFI, although for TNFa, this was less pronounced (Fig. 1B, D) . The observed difference in proportion of responding cells was more pronounced in those T cells producing IFN-c, and in those higher quality T cells that produced both IFN-c and TNFa (double producers). Note that there was no difference in the capacity of Itk 2/2 T cells in producing these cytokines when they were stimulated using PMA/Ionomycin to bypass the TcR (Fig. 1C) . Furthermore, while it is possible that differences in cell viability could be responsible for the differences in cytokine production, we think this is less likely since there was no difference in cell numbers between WT and Itk 2/2 T cells. This suggests that Itk does not regulate proliferative capacity in response to antigen, but regulates the ability of responding CD8
1 T cells to produce IFN-c and TNFa upon TcR restimulation. We also noted that the absence of Itk did not affect the EC 50 for peptide activation, but affected the maximum achievable at specific concentrations, suggesting a digital-type response. WT and Itk 2/2 T cells expressed T-bet and Eomes, particularly at higher doses, and both populations had elevated frequency of Eomes single positive cells at low dose of peptide, but higher frequency of T-bet and T-bet/Eomes double positive cells at the higher doses (Fig. 1E) .
Itk suppresses the development of CD8
1 T cell memory during L. monocytogenes infection. We next examined Itk's role in the CD8 Itk signals negatively regulate the development of MPEC during infection. We followed the differentiation of transferred naïve WT and Itk 2/2 T cells to SLECs and MPECs by examining their expression of CD127 and KLRG1 during infection with LM-OVA. We found a significantly higher frequency of KLRG1 lo /CD127 hi MPECs among the Itk 2/2 T cells, starting at the earliest time point we examined, day 7 (Fig. 2C ). This higher frequency of MPEC generation was not observed at later time points as the WT cells caught up. By contrast, there was no difference in the frequency of SLECs (Fig. 2C) Itk signals negatively regulate CD127 and Eomesodermin expression during infection. The development of MPECs is controlled in part by the expression of Eomes, and we found that a higher frequency of Itk 2/2 T cells expressed Eomes compared to WT T cells 7-21 days post LM-OVA infection. By contrast, there was little difference in the frequency of T-bet expressing cells (Fig. 2D) . Indeed, we found that a higher frequency of Itk 2/2 T cells expressed higher levels of Eomes and its target CD127 at day 7, and the WT T cells do not catch up until day 21. Thus Itk signals suppress early expression of Eomes and CD127 (Fig. 2E) . Berg et al recently suggested that Itk regulates the expression of IRF4, which is a negative regulator of Eomes 26 . However, we did not see any differences in induction of IRF4 when naïve Itk 2/2 T cells are activated by antigen in vitro or in vivo, suggesting that mature peripheral T cells may have different requirements for induction of IRF4 via the TcR (Fig. 2F, G) . These data suggest one explanation for the more efficient conversion of Itk 2/2 T cells to MPEC during infection, earlier and enhanced expression of Eomes, potentially leading to enhanced development of MPECs.
Itk intrinsically promotes cytokine production during the CD8 1 T cell response in vivo in a digital manner. We next examined effector cytokine responses of transferred T cells after LM-OVA infection. We found that both WT and Itk 2/2 T cells responded to infection with cytokine production upon restimulation with the SIINFEKL (Fig. 3A, B) , however, the cells that produced cytokine produced the same amount as WT cells (MFI, Fig. 3A) . These results suggest that Itk signaling is critical for determining whether responding cells will produce cytokine, but not how much cytokine they produce, akin to a digital response.
Itk is not required for antigen specific recall response following infection. Since the absence of Itk enhanced the development of MPEC during infection, we asked whether the resultant memory cells exhibited differential response to reinfection. In contrast to the effector cytokine response during the primary T cell response, there was no difference in effector cytokine production, including frequency or amount/cell (Fig. 4A) . Note that the number of cells upon reinfection was lower in the WT mice, in agreement with the lower number of WT MPECs generated (Fig. 4B, see Fig. 2 ), however, there was no difference in fold expansion between Itk 2/2 and WT cells (ratio Itk 2/2 5WT cell numbers), indicating that reinfection induced similar expansion of memory cells that developed (Fig. 4B) . Indeed, transfer of equal numbers of WT and Itk 2/2 memory CD8
1 T cells into naïve recipients, followed by similar infection with LM-OVA also resulted in statistically similar expansion between the WT and Itk 2/2 memory CD8 1 T cells, although it is possible that the inclusion of more mice in this experiment would reveal a significant difference (Fig. 4C) . Thus, while Itk signals are important in enhancing the frequency of cytokine producing cells within the responding population during a primary T cell response, as well as in delaying the timing of the development of MPECS, these signals are not important for the recall response of the fully differentiated memory population.
Discussion
Early antigen stimulation of CD8
1 T cells via the TcR has been proposed to be an important parameter in regulating the nature of the response, as well as generation of memory. This early TcR signal can be regulated by antigen dose, antigen affinity (for TcR) or intracellular signaling controlling TcR signal strength. TcR signal strength, antigen dose, and antigen affinity have sometimes been used interchangeable, however, they are different parameters. For example, antigen affinity seems to act in an analog manner, altering the EC 50 of peptide required for functional activation as illustrated by Bevan and colleagues 5 . In that case antigen affinity does not affect whether a CD8
1 T cell response is generated, and effector function is not affected. However, there is reduced proliferation and the timing of the T cell contraction is shifted earlier with low affinity antigen. The expression of CD8 can also control the response of CD8
1 T cells in an analog-like fashion, with differences in CD8 altering the EC 50 of peptide required for functional activation in vitro 27 . By contrast, changes in the expression of the protein tyrosine phosphatase SHP-1, which regulates TcR signal strength 28 , does not affect the EC 50 for antigen, but affects the magnitude of the response at the same antigen concentrations in vitro (digital-like) 27 . In vivo SHP-1 regulates the magnitude of the peak of the CD8 1 T cell response, along with the frequency of SLECs generated, without affecting the effector cytokine or MPECs generated 29 . Our results indicate that as a regulator of TcR signaling in the vein of SHP-1, Itk acts in digital-like manner for the cytokine response, with little effect on the effectiveness of antigen activation (EC 50 ), but on the likelihood that responding cells will produce cytokine. Our results also suggest that Itk acts in a ''tuning'' capacity in regulating the ability of cells to differentiate to MPECs, and thus generate memory cells.
Stimulating CD8 1 T cells carrying a TcRb chain that reduces signaling results in reduced development of memory, without affecting development of effector responses 30 , and reducing the affinity of the TcR ligands can rescue the development of memory in these cells 31 . This rescue of memory development in these T cells is suggested to be due to NFkB signaling 31 . These data suggests that reduced TcR signaling leads to reduced development of effector and memory cells. Our data with Itk deficient T cells, which also exhibit reduced TcR signaling, provides a different view, in that we observe normal effector cell development, but enhanced memory development. Of course, while CD8 1 T cells carrying the altered TcRb chain do exhibit reduced TcR signaling, they may also have other signaling pathways that are altered, that may affect effector and memory cell development, particularly since memory development in these cells can be rescued by using a lower affinity ligand 30, 31 . The groups of Jordan as well as of Teixeiro have previously shown that weak TCR signaling favors the generation of memory CD8 T cells 31, 32 . Indeed, the work of Smith-Garvin et al use, among others, a SLP-76 Y145F mutant which regulates its interaction with Itk, and our work with Itk leads to similar conclusions regarding the role of this pathway on regulating the development of memory CD8 1 T cells. Thus our data are in support of the idea that weak TCR signals preferentially allow the development of CD8 1 memory T cells. We found that Itk 2/2 T cells exhibit early expression of Eomes, and the mechanism is of considerable interest. Berg et al recently suggested that Itk regulates the expression of IRF4, which is a negative regulator of Eomes 26 . However, these experiments were performed using Itk 2/2 thymocytes, which, as discussed earlier, may have developmental differences compared to WT T cells. In our experiments we have not seen any differences in induction of IRF4 when naïve Itk 2/2 OTI/Rag 2/2 T cells are activated by antigen in vitro or in vivo, suggesting that mature peripheral T cells may have different requirements for induction of IRF4 via the TcR. Of significant interest is the recent report that Eomes is regulated by the small GTPase, N-Ras, and that the absence of N-Ras in naïve T cell results in reduced development of MPECs 33 . As Itk deficient T cells exhibit the inverse phenotype, this would suggest that Itk negatively regulates N-Ras activity, and in its absence, there is elevated expression of Eomes. As previous studies have shown, Itk regulates the activation of the Ras/MAPK pathway downstream of the TcR 34 , although this regulation may be more complex. This differential regulation of Eomes may endow Itk 2/2 T cells with the ability to generate early MPECs. During the immune response, an increase in SLEC has been suggested to reduce the availability of precursors able to become MPECs 35 . This increase in SLEC is suggested to reduce the availability of precursors able to become MPECs. Our data suggest that these may be separable events, and that enhanced early MPEC development can occur in the face of apparently normal SLEC development. While it can be difficult to untangle the effects of differences in bacterial clearance, and the corresponding effects on inflammation, we note that there is no difference in bacterial clearance between WT and Itk 2/2 T cell recipients, suggesting that this is not likely to be a factor in the differential development of MPECs. Our work therefore supports a model where weaker TCR signals due to lack of Itk in CD8 1 T cells contributes to the promotion of earlier MPEC development.
The findings reported in this work, along with our recently reported findings on the development of innate memory phenotype 1 T cells 21 . We suggest that similar to the development of IMP CD8 1 T cells driven by IL-4, development of MPECs driven by cytokines regulating this process may be tuned by TCR signals traveling via Itk.
In contrast to developing Itk 2/2 effector T cells, Itk 2/2 CD8 1 memory T cells were able to respond equivalent to WT cells in both frequency and cytokine expression upon bacterial rechallenge. This supports previous work showing that TcR signaling is different between naive and memory T cells (see review 36 ), such that there may be less of a dependence on Itk signals for cytokine expression. Based on these findings, there is a strong potential for the use of Itk inhibitors in manipulating the CD8 1 T cell response to enhance early development of memory without compromising memory recall responses. TcR signal strength has been proposed as a parameter that determines the CD8 1 T cell response, including memory development 1 . We have referred here to the behavior of Itk in regulating these pathways as acting in a digital manner (in regulating cytokine production), and as a tuner (in regulating memory cell development). We refer to the digital response with regards to the cytokine response, in that while the percent of cells that produce cytokine in vitro and in vivo is different between WT and Itk 2/2 T cells, the amount of cytokine that they make (as read out by MFI) is not different. This suggests that Itk signals control whether the cells will respond (digital), but not the amount of cytokine that the responding cells make (which we propose would be an analog response). We refer to Itk as a tuner in regulating memory cell development since the absence of Itk enhances memory cell development in a seeming analog manner, not whether they will develop into memory cells, suggesting an analog like behavior controllable by a tuner. 6 CFU/mouse via IP injection. At the indicated time after LM-OVA infection, mice were sacrificed and blood, spleen, and lymph nodes were harvested. For memory T cell expansion studies, purified naïve CD45.1 WT or Itk 2/2 T cells were transferred into CD45.1 congenic WT mice. Recipient mice were then infected with LM-OVA (5 3 10 6 CFU/mouse) as previously described. After 30 days, memory donor CD45.2 CD8
1 T cells were isolated by FACS, then transferred (40,000/mouse) into naïve mice, which were infected with 103 the initial dose of bacteria, and number of donor CD45.2 CD8
1 T cells analyzed 3 days post-infection.
Cell isolation and purification. Naïve T cells were purified from spleen or lymph nodes of WT and Itk 2/2 OTI/Rag 2/2 mice by negative selection using: biotin-anti-Fc block, biotin-anti-F4/80, biotin-anti-CD11c, biotin-anti-CD11b, biotin-anti-CD49b, biotin-anti-DX5, biotin-anti-Ter119, biotin-anti-Gr-1, and biotin-anti-CD25 (eBiosciences Inc). Negative selection of purified naïve T cells was done by anti-biotin beads and MACS columns, and verified by FACS.
Cell culture and stimulation conditions. Complete RPMI (Invitrogen Inc) with 10% FBS was used for cell culture. Purified naïve T cells were cultured at a concentration of 10 6 /ml with mitomycin C-treated splenocytes (as APCs) from Rag 2/2 mice (ratio 155). OVA 257-264 peptide (SIINFEKL, Peptides International Inc.) at the indicated concentrations (10 28 mM to 1 mM) was used and cells cultured for five days. On the 5 th day, cells were restimulated with SIINFEKL peptide at the same concentration used for the original culture, or PMA (20 ng/ml)/Ionomycin (2 mM) (P/I) for 4-6 hours in the presence of Brefeldin A (BFA, 100 mg/ml, Sigma Aldrich, Inc). For cells from LM-OVA infection, cells were stimulated with 1 mM SIINFEKL peptide or P/I in the presence of BFA for 4-6 hours.
FACS analysis. Blood samples were collected in 50 U/ml heparin (Sigma Aldrich, Inc.), and ACK (Ammonium-Chloride-Potassium) lysis buffer before FACS analysis. The following antibodies were used: FITC-anti-KLRG1, APC-anti-CD45.1, PECy7-anti-CD127, Pacific Blue-anti-CD122, PerCP-Cy 5.5-anti-EOMES, PECy7-anti-IFNc (eBiosciences Inc.), PE-anti-CD62L, PE-anti-Thy1a, APC-Cy7-anti-CD45.2, Alexa-Fluor-700-anti-CD62L, Horizon-V500-anti-CD44, PE-anti-TNFa, APC-anti-T-bet, PE-CF594-CD8a, ACP-Cy7-TCRVa2 and AlexaFluor700-anti-Ki67 (BD Biosciences, Inc.), ECD-Texas Red-anti-CD8a (Invitrogen, Inc.), Fc Block, FITC-CD45.2, and AF700-CD45.2 (Biolegend). MFI was determined by gating on cytokine positive populations. All transferred cells analyzed were gated by CD8 
